PROCEPT BioRobotics (PRCT) CEO granted large new option and RSU awards

Rhea-AI Filing Summary

PROCEPT BioRobotics President and CEO Larry L. Wood received equity awards on March 5, 2026. He was granted 103,653 stock options at an exercise price of $0.00 per share and 127,783 restricted stock units (RSUs) of common stock.

The RSUs vest over four years, with one-quarter vesting on March 5, 2027 and the remainder vesting quarterly over 36 months, conditioned on continued service. The stock options vest monthly over four years from March 5, 2026, also subject to continued employment or service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wood Larry L

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		127,783(1)	A	$0	313,378	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$25.35	03/05/2026		A		103,653		(2)	03/04/2036	Common Stock	103,653	$0	103,653	D

Explanation of Responses:

1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

2. 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

Remarks:

	/s/ Jonathan Stone, as Attorney-in-Fact for Larry Wood	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PRCT CEO Larry Wood acquire in this Form 4 filing?

Larry Wood received equity awards consisting of 103,653 stock options and 127,783 restricted stock units. Both awards relate to PROCEPT BioRobotics common stock and are structured to vest over several years, tying his compensation to continued service with the company.

How do the new RSUs for PRCT CEO Larry Wood vest?

The 127,783 RSUs vest over four years. One-quarter vests on March 5, 2027, and the remaining three-quarters vest in equal quarterly installments over the following 36 months, contingent on Larry Wood continuing as a service provider through each applicable vesting date.

What is the vesting schedule for Larry Wood’s new stock options at PRCT?

The 103,653 stock options vest in 48 equal monthly installments. Vesting starts on March 5, 2026, and continues over four years, with each month’s tranche requiring Larry Wood’s continued employment or service with PROCEPT BioRobotics through the respective vesting date.

Are Larry Wood’s new PRCT equity awards granted at a purchase price?

The reported transaction price per share is $0.00 for both the stock options and the RSUs. This reflects that they are compensatory grants, not open-market purchases, and their value depends on future stock performance and satisfaction of vesting conditions.

How many PRCT common shares does Larry Wood hold after these grants?

After the March 5, 2026 grant of 127,783 RSUs, Larry Wood is reported as beneficially owning 313,378 shares of PROCEPT BioRobotics common stock directly. This figure includes the newly awarded RSUs subject to the described multi-year vesting schedule and service conditions.